Do statins and hormonal replacement therapy in combination reduce cardiovascular risk in postmenopausal women?
نویسندگان
چکیده
منابع مشابه
Do statins and hormonal replacement therapy in combination reduce cardiovascular risk in postmenopausal women?
[1] Elizari MV, Martı́nez JM, Belziti C et al. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. Eur Heart J 2000; 21: 198–205. [2] Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic...
متن کاملBreast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.
OBJECTIVES Testosterone supplementation can be considered as a treatment option for surgically postmenopausal women with a distressful low sexual desire disorder, while on oestrogen therapy with or without progestagens. The purpose of this study is to review the available clinical data on the impact of exogenous testosterone containing postmenopausal hormone therapy on breast cancer risk. MET...
متن کاملHormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
Hormone replacement therapy may protect against cardiovascular disease through several mechanisms that have variable actions on the major determinants of plasma viscosity. Plasma viscosity is an important predictor of incident and recurrent cardiovascular events and mortality in coronary heart disease patients. The effect of estrogen alone or in combination with progestin on plasma viscosity is...
متن کاملEffect of Estrogen Replacement Therapy on Metabolic Risk Factors for Cardiovascular Diseases in Hysterectomized Postmenopausal Women
Estrogen replacement therapy (ERT) has been associated with favorable effects on risk factors for atherosclerosis. In observational studies ERT was also suggested to reduce the risk of cardiovascular disease in postmenopausal women, but the cardioprotective role of estrogen has been challenged after negative results in randomized trials. However, the mechanisms of estrogen action in atheroscler...
متن کاملSerum vitamin A status in women users of lowdose oral contraceptives and in postmenopausal women taking hormone replacement therapy.
Background: One of the most important nonenzymatic antioxidant defense systems is vitamin A, and is considered as an important dietary agent for reducing cardiovascular diseases. Objective: The objective of this study was to investigate the serum vitamin A status in women who used low-dose oral contraceptives (OCs) containing 0.15 mg levonorgestrol and 0.03 mg ethinyl estradiol and also in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2000
ISSN: 0195-668X
DOI: 10.1053/euhj.1999.1895